您当前所在的位置:首页 > 产品中心 > 产品详细信息
146623-69-0 分子结构
点击图片或这里关闭

1-{[3-bromo-2-(2-trifluoromethanesulfonamidophenyl)-1-benzofuran-5-yl]methyl}-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboxamide

ChemBase编号:1176
分子式:C25H22BrF3N4O4S
平均质量:611.4307896
单一同位素质量:610.04972286
SMILES和InChIs

SMILES:
Brc1c2cc(Cn3c(c(nc3CC)C3CC3)C(=O)N)ccc2oc1c1c(NS(=O)(=O)C(F)(F)F)cccc1
Canonical SMILES:
CCc1nc(c(n1Cc1ccc2c(c1)c(Br)c(o2)c1ccccc1NS(=O)(=O)C(F)(F)F)C(=O)N)C1CC1
InChI:
InChI=1S/C25H22BrF3N4O4S/c1-2-19-31-21(14-8-9-14)22(24(30)34)33(19)12-13-7-10-18-16(11-13)20(26)23(37-18)15-5-3-4-6-17(15)32-38(35,36)25(27,28)29/h3-7,10-11,14,32H,2,8-9,12H2,1H3,(H2,30,34)
InChIKey:
DUEWVPTZCSAMNB-UHFFFAOYSA-N

引用这个纪录

CBID:1176 http://www.chembase.cn/molecule-1176.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
1-{[3-bromo-2-(2-trifluoromethanesulfonamidophenyl)-1-benzofuran-5-yl]methyl}-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboxamide
IUPAC传统名
3-{[3-bromo-2-(2-trifluoromethanesulfonamidophenyl)-1-benzofuran-5-yl]methyl}-5-cyclopropyl-2-ethylimidazole-4-carboxamide
别名
Saprisartan
CAS号
146623-69-0
PubChem SID
160964638
46508176
PubChem CID
60921

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB01347 external link
PubChem 60921 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
质子受体 质子供体
LogD (pH = 5.5) 4.1792154  LogD (pH = 7.4) 4.3395157 
Log P 3.3470178  摩尔折射率 137.1475 cm3
极化性 54.258743 Å3 极化表面积 120.22 Å2
可自由旋转的化学键 里宾斯基五规则 false 
Acid pKa 2.2661362 
Log P 5.89  LOG S -4.61 
溶解度 1.51e-02 g/l 

分子性质

分子性质

生物活性(PubChem)

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB01347 external link
Item Information
Drug Groups approved
Description Saprisartan is an AT1 receptor antagonist. It is based on medications of losartan's prototypical chemical structure. The mode of (functional) AT1 receptor antagonism has been characterized as insurmountable/noncompetitive for saprisartan. It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism.(10579749)
Indication Saprisartan is used in the treatment of hypertension and heart failure.
Pharmacology By inhibiting the angiotensin II receptor, this drug leades to a decrease in sodium reabsorption and a decrease in vasoconstriction. This has the combined effect of decreasing blood pressure.
Affected Organisms
Humans and other mammals

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    暂无数据
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle